What you eat is what you are - A role for polyunsaturated fatty acids in neuroinflammation induced depression?

Clinical Nutrition

Volumn 30, Issue 4, 2011, Pages 407-415

  Pascoe, Michaela C ^a,b,c   Crewther, Sheila G ^c   Carey, Leeanne M ^b,c   Crewther, David P ^a  

^a SWINBURNE UNIVERSITY OF TECHNOLOGY   (Australia)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

Author keywords

Apoptosis; Cytokine; Depression; Ischemia; Myocardial infarction; Polyunsaturated fatty acid

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; ARACHIDONIC ACID; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FISH OIL; FREE RADICAL; ICOSANOID; ICOSAPENTAENOIC ACID; IMMUNOMODULATING AGENT; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; OXIDIZING AGENT; PROSTAGLANDIN E RECEPTOR 3; PROSTAGLANDIN E RECEPTOR 4; PROSTAGLANDIN E2; PROSTAGLANDIN E3; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CONCENTRATION RESPONSE; CORTICOSTERONE RELEASE; CYTOKINE RELEASE; DEPRESSION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DRUG MECHANISM; ENZYME REGULATION; EXCITOTOXICITY; FATTY ACID BLOOD LEVEL; HUMAN; IMMUNOMODULATION; INTRACELLULAR SIGNALING; NAUSEA; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SLEEP DISORDER;

ANIMALS; ANTI-INFLAMMATORY AGENTS; APOPTOSIS; CYTOKINES; DEPRESSIVE DISORDER; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; HUMANS; INFLAMMATION; MODELS, ANIMAL; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; OXIDANTS; PROSTAGLANDINS;

EID: 79960698192     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2011.03.013     Document Type: Review

References (146)

1. Maes M. The cytokine hypothesis of depression: inflammation, oxidative & nitrosative stress (IO&NS) and leaky gut as new targets for adjunctive treatments in depression. Neuro Endocrinol Lett 2008, 29:287-291.
2. Frasure-Smith N., Lesperance F. Depression and other psychological risks following myocardial infarction. Arch Gen Psychiatry 2003, 60:627-636.
3. Hackett M.L., Yapa C., Parag V., Anderson C.S. Frequency of depression after stroke: a systematic review of observational studies. Stroke 2005, 36:1330-1340.
4. Linden T., Blomstrand C., Skoog I. Depressive disorders after 20 months in elderly stroke patients: a case-control study. Stroke 2007, 38:1860-1863.
5. Dantzer R. Cytokine-induced sickness behavior: mechanisms and implications. Ann N Y Acad Sci 2001, 933:222-234.
6. Capuron L., Dantzer R. Cytokines and depression: the need for a new paradigm. Brain Behav Immun 2003, 17(Suppl 1):S119-S124.
7. Sagoo P., Chan G., Larkin D.F., George A.J. Inflammatory cytokines induce apoptosis of corneal endothelium through nitric oxide. Invest Ophthalmol Vis Sci 2004, 45:3964-3973.
8. Eilat E., Mendlovic S., Doron A., Zakuth V., Spirer Z. Increased apoptosis in patients with major depression: A preliminary study. J Immunol 1999, 163(1):533-534.
9. Harlan J., Chen Y., Gubbins E., Mueller R., Roch J.M., Walter K., et al. Variants in Apaf-1 segregating with major depression promote apoptosome function. Mol Psychiatry 2006, 11:76-85.
10. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr 2000, 71:343S-348S.
11. Wu Y., Tada M., Takahata K., Tomizawa K., Matsui H. Inhibitory effect of polyunsaturated fatty acids on apoptosis induced by etoposide, okadaic acid and AraC in Neuro2a cells. Acta Med Okayama 2007, 61:147-152.
12. Blok W.L., Katan M.B., van der Meer J.W. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr 1996, 126:1515-1533.
13. Hibbeln J.R. Fish consumption and major depression. Lancet 1998, 351:1213.
14. Gomez-Pinilla F. Brain foods: the effects of nutrients on brain function. Nat Rev Neurosci 2008, 9:568-578.
15. Psota T.L., Gebauer S.K., Kris-Etherton P. Dietary omega-3 fatty acid intake and cardiovascular risk. Am J Cardiol 2006, 98:3i-18i.
16. Das U.N. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 2006, 1:420-439.
17. Funk C.D. Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 2001, 294:1871-1875.
18. Su K.P. Biological mechanism of antidepressant effect of omega-3 fatty acids: how does fish oil act as a 'mind-body interface'?. Neurosignals 2009, 17:144-152.
19. Simopoulos A.P. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr 1991, 54:438-463.
20. Fernandes G., Chandrasekar B., Luan X., Troyer D.A. Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids 1996, 31(Suppl, S91-96).
21. Levine J., Barak Y., Chengappa K.N., Rapoport A., Rebey M., Barak V. Cerebrospinal cytokine levels in patients with acute depression. Neuropsychobiology 1999, 40(4):171-176.
22. Konsman J.P., Parnet P., Dantzer R. Cytokine-induced sickness behaviour: mechanisms and implications. Trends Neurosci 2002, 25:154-159.
23. Parsadaniantz S.M., Lebeau A., Duval P., Grimaldi B., Terlain B., Kerdelhue B. Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat. J Neuroendocrinol 2000, 12(8):766-773.
24. Kelley D.S., Taylor P.C., Nelson G.J., Schmidt P.C., Ferretti A., Erickson K.L., et al. Docosahexaenoic acid ingestion inhibits natural killer cell activity and production of inflammatory mediators in young healthy men. Lipids 1999, 34(4):317-324.
25. Breyer R.M., Bagdassarian C.K., Myers S.A., Breyer M.D. Prostanoid receptors: subtypes and signaling. Annu Rev Pharmacol Toxicol 2001, 41:661-690.
26. Zhang J., Rivest S. Distribution, regulation and colocalization of the genes encoding the EP2- and EP4-PGE2 receptors in the rat brain and neuronal responses to systemic inflammation. Eur J Neurosci 1999, 11:2651-2668.
27. Hill M.N., Carrier E.J., McLaughlin R.J., Morrish A.C., Meier S.E., Hillard C.J., et al. Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment. J Neurochem 2008, 106(6):2322-2336.
28. Henderson B., Pettipher E.R., Higgs G.A. Mediators of rheumatoid arthritis. Br Med Bull 1987, 43:415-428.
29. Koller M., Wachtler P., David A., Muhr G., Konig W. Arachidonic acid induces DNA-fragmentation in human polymorphonuclear neutrophil granulocytes. Inflammation 1997, 21:463-474.
30. Seegers J.C., de Kock M., Lottering M.L., Grobler C.J., van Papendorp D.H., Shou Y., et al. Effects of gamma-linolenic acid and arachidonic acid on cell cycle progression and apoptosis induction in normal and transformed cells. Prostaglandins Leukot Essent Fatty Acids 1997, 56(4):271-280.
31. Suzuki K., Tadakuma T., Kizaki H. Modulation of thymocyte apoptosis by isoproterenol and prostaglandin E2. Cell Immunol 1991, 134:235-240.
32. Pica F., Franzese O., D'Onofrio C., Bonmassar E., Favalli C., Garaci E. Prostaglandin E2 induces apoptosis in resting immature and mature human lymphocytes: a c-Myc-dependent and Bcl-2-independent associated pathway. J Pharmacol Exp Ther 1996, 277(3):1793-1800.
33. Gong J.H., Renz H., Sprenger H., Nain M., Gemsa D. Enhancement of tumor necrosis factor-alpha gene expression by low doses of prostaglandin E2 and cyclic GMP. Immunobiology 1990, 182:44-55.
34. Das U.N., Mohan I.K., Raju T.R. Effect of corticosteroids and eicosapentaenoic acid/docosahexaenoic acid on pro-oxidant and anti-oxidant status and metabolism of essential fatty acids in patients with glomerular disorders. Prostaglandins Leukot Essent Fatty Acids 2001, 65:197-203.
35. Song C., Li X., Leonard B.E., Horrobin D.F. Effects of dietary n-3 or n-6 fatty acids on interleukin-1beta-induced anxiety, stress, and inflammatory responses in rats. J Lipid Res 2003, 44:1984-1991.
36. Parrott R.F., Vellucci S.V. Effects of centrally administered prostaglandin EP receptor agonists on febrile and adrenocortical responses in the prepubertal pig. Brain Res Bull 1996, 41:97-103.
37. Hosoi M., Oka T., Hori T. Prostaglandin E receptor EP3 subtype is involved in thermal hyperalgesia through its actions in the preoptic hypothalamus and the diagonal band of Broca in rats. Pain 1997, 71:303-311.
38. Ushikubi F., Segi E., Sugimoto Y., Murata T., Matsuoka T., Kobayashi T., et al. Impaired febrile response in mice lacking the prostaglandin E receptor subtype EP3. Nature 1998, 395(6699):281-284.
39. Uehara A., Ishikawa Y., Okumura T., Okamura K., Sekiya C., Takasugi Y., et al. Indomethacin blocks the anorexic action of interleukin-1. Eur J Pharmacol 1989, 170(3):257-260.
40. Cao C., Matsumura K., Yamagata K., Watanabe Y. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am J Physiol 1997, 272:R1712-R1725.
41. Ericsson A., Arias C., Sawchenko P.E. Evidence for an intramedullary prostaglandin-dependent mechanism in the activation of stress-related neuroendocrine circuitry by intravenous interleukin-1. J Neurosci 1997, 17:7166-7179.
42. Jakobsson P.J., Thoren S., Morgenstern R., Samuelsson B. Identification of human prostaglandin E synthase: a microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target. Proc Natl Acad Sci U S A 1999, 96:7220-7225.
43. Labow M., Shuster D., Zetterstrom M., Nunes P., Terry R., Cullinan E.B., et al. Absence of IL-1 signaling and reduced inflammatory response in IL-1 type I receptor-deficient mice. J Immunol 1997, 159(5):2452-2461.
44. Laflamme N., Lacroix S., Rivest S. An essential role of interleukin-1beta in mediating NF-kappaB activity and COX-2 transcription in cells of the blood-brain barrier in response to a systemic and localized inflammation but not during endotoxemia. J Neurosci 1999, 19:10923-10930.
45. Vane S.J. Differential inhibition of cyclooxygenase isoforms an explanation of the action of NSAIDs. J Clin Rheumatol 1998, 4:3-10.
46. Schmedtje J.F., Ji Y.S., Liu W.L., DuBois R.N., Runge M.S. Hypoxia induces cyclooxygenase-2 via the NF-kappaB p65 transcription factor in human vascular endothelial cells. J Biol Chem 1997, 272:601-608.
47. Lacroix S., Rivest S. Effect of acute systemic inflammatory response and cytokines on the transcription of the genes encoding cyclooxygenase enzymes (COX-1 and COX-2) in the rat brain. J Neurochem 1998, 70:452-466.
48. Crofford L.J., Tan B., McCarthy C.J., Hla T. Involvement of nuclear factor kappa B in the regulation of cyclooxygenase-2 expression by interleukin-1 in rheumatoid synoviocytes. Arthritis Rheum 1997, 40:226-236.
49. Ohishi K., Ueno R., Nishino S., Sakai T., Hayaishi O. Increased level of salivary prostaglandins in patients with major depression. Biol Psychiatry 1988, 23:326-334.
50. Freeman M.P., Hibbeln J.R., Wisner K.L., Davis J.M., Mischoulon D., Peet M., et al. Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006, 67(12):1954-1967.
51. Song C., Phillips A.G., Leonard B.E., Horrobin D.F. Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1beta in rats. Mol Psychiatry 2004, 9:630-638.
52. Noponen M., Sanfilipo M., Samanich K., Ryer H., Ko G., Angrist B., et al. Elevated PLA2 activity in schizophrenics and other psychiatric patients. Biol Psychiatry 1993, 34(9):641-649.
53. Song C., Zhang X.Y., Manku M. Increased phospholipase A2 activity and inflammatory response but decreased nerve growth factor expression in the olfactory bulbectomized rat model of depression: effects of chronic ethyl-eicosapentaenoate treatment. J Neurosci 2009, 29:14-22.
54. Lucassen P.J., Fuchs E., Czeh B. Antidepressant treatment with tianeptine reduces apoptosis in the hippocampal dentate gyrus and temporal cortex. Biol Psychiatry 2004, 55:789-796.
55. Rao J.S., Lee H.J., Rapoport S.I., Bazinet R.P. Mode of action of mood stabilizers: is the arachidonic acid cascade a common target?. Mol Psychiatry 2008, 13:585-596.
56. Florent S., Malaplate-Armand C., Youssef I., Kriem B., Koziel V., Escanye M.C., et al. Docosahexaenoic acid prevents neuronal apoptosis induced by soluble amyloid-beta oligomers. J Neurochem 2006, 96(2):385-395.
57. Thomas A.J., Davis S., Morris C., Jackson E., Harrison R., O'Brien J.T. Increase in interleukin-1beta in late-life depression. Am J Psychiatry 2005, 162(1):175-177.
58. Tuglu C., Kara S.H., Caliyurt O., Vardar E., Abay E. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder. Psychopharmacology (Berl) 2003, 170:429-433.
59. Yaron I., Shirazi I., Judovich R., Levartovsky D., Caspi D., Yaron M. Fluoxetine and amitriptyline inhibit nitric oxide, prostaglandin E2, and hyaluronic acid production in human synovial cells and synovial tissue cultures. Arthritis Rheum 1999, 42(12):2561-2568.
60. Endres S., Meydani S.N., Ghorbani R., Schindler R., Dinarello C.A. Dietary supplementation with n-3 fatty acids suppresses interleukin-2 production and mononuclear cell proliferation. J Leukoc Biol 1993, 54:599-603.
61. Endres S., Ghorbani R., Kelley V.E., Georgilis K., Lonnemann G., van der Meer J.W., et al. The effect of dietary supplementation with n-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells. N Engl J Med 1989, 320(5):265-271.
62. Caughey G.E., Mantzioris E., Gibson R.A., Cleland L.G., James M.J. The effect on human tumor necrosis factor alpha and interleukin 1 beta production of diets enriched in n-3 fatty acids from vegetable oil or fish oil. Am J Clin Nutr 1996, 63:116-122.
63. de Pablo M.A., Ortega E., Gallego A.M., Alvarez C., Pancorbo P.L., Alvarez de Cienfuegos G. The effect of dietary fatty acid manipulation on phagocytic activity and cytokine production by peritoneal cells from Balb/c mice. J Nutr Sci Vitaminol (Tokyo) 1998, 44(1):57-67.
64. Soyland E., Lea T., Sandstad B., Drevon A. Dietary supplementation with very long-chain n-3 fatty acids in man decreases expression of the interleukin-2 receptor (CD25) on mitogen-stimulated lymphocytes from patients with inflammatory skin diseases. Eur J Clin Invest 1994, 24:236-242.
65. Chandrasekar B., Fernandes G. Decreased pro-inflammatory cytokines and increased antioxidant enzyme gene expression by omega-3 lipids in murine lupus nephritis. Biochem Biophys Res Commun 1994, 200:893-898.
66. Barone J., Hebert J.R., Reddy M.M. Dietary fat and natural-killer-cell activity. Am J Clin Nutr 1989, 50:861-867.
67. Maes M., Christophe A., Bosmans E., Lin A., Neels H. In humans, serum polyunsaturated fatty acid levels predict the response of proinflammatory cytokines to psychologic stress. Biol Psychiatry 2000, 47:910-920.
68. Song C., Leonard B.E., Horrobin D.F. Dietary ethyl-eicosapentaenoic acid but not soybean oil reverses central interleukin-1-induced changes in behavior, corticosterone and immune response in rats. Stress 2004, 7:43-54.
69. Maes M., Song C., Lin A.H., Bonaccorso S., Kenis G., De Jongh R., et al. Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology 1999, 20(4):370-379.
70. Kubera M., Holan V., Mathison R., Maes M. The effect of repeated amitriptyline and desipramine administration on cytokine release in C57BL/6 mice. Psychoneuroendocrinology 2000, 25:785-797.
71. Das U.N. Essential fatty acids and their metabolites could function as endogenous HMG-CoA reductase and ACE enzyme inhibitors, anti-arrhythmic, anti-hypertensive, anti-atherosclerotic, anti-inflammatory, cytoprotective, and cardioprotective molecules. Lipids Health Dis 2008, 7:37.
72. Marcheselli V.L., Hong S., Lukiw W.J., Tian X.H., Gronert K., Musto A., et al. Novel docosanoids inhibit brain ischemia-reperfusion-mediated leukocyte infiltration and pro-inflammatory gene expression. J Biol Chem 2003, 278(44):43807-43817.
73. Shapiro A.C., Wu D., Meydani S.N. Eicosanoids derived from arachidonic and eicosapentaenoic acids inhibit T cell proliferative response. Prostaglandins 1993, 45:229-240.
74. Kanematsu M., Ikeda K., Yamada Y. Interaction between nitric oxide synthase and cyclooxygenase pathways in osteoblastic MC3T3-E1 cells. J Bone Miner Res 1997, 12:1789-1796.
75. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese J., Spur B.W., et al. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Engl J Med 1985, 312(19):1217-1224.
76. Ross B.M., Seguin J., Sieswerda L.E. Omega-3 fatty acids as treatments for mental illness: which disorder and which fatty acid?. Lipids Health Dis 2007, 6:21.
77. Maes M., Smith R., Christophe A., Cosyns P., Desnyder R., Meltzer H. Fatty acid composition in major depression: decreased omega 3 fractions in cholesteryl esters and increased C20: 4 omega 6/C20:5 omega 3 ratio in cholesteryl esters and phospholipids. J Affect Disord 1996, 38(1):35-46.
78. Sublette M.E., Hibbeln J.R., Galfalvy H., Oquendo M.A., Mann J.J. Omega-3 polyunsaturated essential fatty acid status as a predictor of future suicide risk. Am J Psychiatry 2006, 163:1100-1102.
79. Peet M., Murphy B., Shay J., Horrobin D. Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients. Biol Psychiatry 1998, 43:315-319.
80. McNamara R.K., Hahn C.G., Jandacek R., Rider T., Tso P., Stanford K.E., et al. Selective deficits in the omega-3 fatty acid docosahexaenoic acid in the postmortem orbitofrontal cortex of patients with major depressive disorder. Biol Psychiatry 2007, 62(1):17-24.
81. Hibbeln J.R., Linnoila M., Umhau J.C., Rawlings R., George D.T., Salem N. Essential fatty acids predict metabolites of serotonin and dopamine in cerebrospinal fluid among healthy control subjects, and early- and late-onscoholics. Biol Psychiatry 1998, 44(4):235-242.
82. Kozak W., Soszynski D., Rudolph K., Conn C.A., Kluger M.J. Dietary n-3 fatty acids differentially affect sickness behavior in mice during local and systemic inflammation. Am J Physiol 1997, 272:R1298-R1307.
83. Hibbeln J.R., Salem N. Dietary polyunsaturated fatty acids and depression: when cholesterol does not satisfy. Am J Clin Nutr 1995, 62:1-9.
84. Conklin S.M., Gianaros P.J., Brown S.M., Yao J.K., Hariri A.R., Manuck S.B., et al. Long-chain omega-3 fatty acid intake is associated positively with corticolimbic gray matter volume in healthy adults. Neurosci Lett 2007, 421(3):209-212.
85. Duman R.S. Depression: a case of neuronal life and death?. Biol Psychiatry 2004, 56:140-145.
86. Tanskanen A., Hibbeln J.R., Hintikka J., Haatainen K., Honkalampi K., Viinamaki H. Fish consumption, depression, and suicidality in a general population. Arch Gen Psychiatry 2001, 58(5):512-513.
87. Schatzberg A.F. Safety and tolerability of antidepressants: weighing the impact on treatment decisions. J Clin Psychiatry 2007, 8(68 Suppl):26-34.
88. Yano M., Kishida E., Iwasaki M., Kojo S., Masuzawa Y. Docosahexaenoic acid and vitamin E can reduce human monocytic U937 cell apoptosis induced by tumor necrosis factor. J Nutr 2000, 130:1095-1101.
89. Kishida E., Yano M., Kasahara M., Masuzawa Y. Distinctive inhibitory activity of docosahexaenoic acid against sphingosine-induced apoptosis. Biochim Biophys Acta 1998, 1391:401-408.
90. Kim H.Y., Akbar M., Lau A., Edsall L. Inhibition of neuronal apoptosis by docosahexaenoic acid (22:6n-3). Role of phosphatidylserine in antiapoptotic effect. J Biol Chem 2000, 275:35215-35223.
91. Akbar M., Kim H.Y. Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J Neurochemistry 2002, 82:655-665.
92. Mebarek S., Ermak N., Benzaria A., Vicca S., Dubois M., Nemoz G., et al. Effects of increasing docosahexaenoic acid intake in human healthy volunteers on lymphocyte activation and monocyte apoptosis. Br J Nutr 2009, 101(6):852-858.
93. Rotstein N.P., Aveldano M.I., Barrantes F.J., Roccamo A.M., Politi L.E. Apoptosis of retinal photoreceptors during development in vitro: protective effect of docosahexaenoic acid. J Neurochem 1997, 69:504-513.
94. Grilli M., Pizzi M., Memo M., Spano P. Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 1996, 274:1383-1385.
95. Mukherjee P.K., Marcheselli V.L., Serhan C.N., Bazan N.G. Neuroprotectin D1: a docosahexaenoic acid-derived docosatriene protects human retinal pigment epithelial cells from oxidative stress. Proc Natl Acad Sci U S A 2004, 101:8491-8496.
96. Hwang J., Zheng L.T., Ock J., Lee M.G., Kim S.H., Lee H.W., et al. Inhibition of glial inflammatory activation and neurotoxicity by tricyclic antidepressants. Neuropharmacology 2008, 55(5):826-834.
97. Pace T.W., Mletzko T.C., Alagbe O., Musselman D.L., Nemeroff C.B., Miller A.H., et al. Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am J Psychiatry 2006, 163(9):1630-1633.
98. Lukiw W.J., Cui J.G., Marcheselli V.L., Bodker M., Botkjaer A., Gotlinger K., et al. A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. J Clin Invest 2005, 115(10):2774-2783.
99. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature 2000, 407:802-809.
100. Cregan S.P., Dawson V.L., Slack R.S. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene 2004, 23:2785-2796.
101. Bas O., Songur A., Sahin O., Mollaoglu H., Ozen O.A., Yaman M., et al. The protective effect of fish n-3 fatty acids on cerebral ischemia in rat hippocampus. Neurochem Int 2007, 50(3):548-554.
102. Mergenthaler P., Dirnagl U., Meisel A. Pathophysiology of stroke: lessons from animal models. Metab Brain Dis 2004, 19:151-167.
103. Bal-Price A., Brown G.C. Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. J Neurosci 2001, 21:6480-6491.
104. Tani M., Neely J.R. Role of intracellular Na+ in Ca2+ overload and depressed recovery of ventricular function of reperfused ischemic rat hearts. Possible involvement of H+-Na+ and Na+-Ca2+ exchange. Circ Res 1989, 65:1045-1056.
105. White R.J., Reynolds I.J. Mitochondria accumulate Ca2+ following intense glutamate stimulation of cultured rat forebrain neurones. J Physiol 1997, 498(Pt 1):31-47.
106. Back T., Kohno K., Hossmann K.A. Cortical negative DC deflections following middle cerebral artery occlusion and KCl-induced spreading depression: effect on blood flow, tissue oxygenation, and electroencephalogram. J Cereb Blood Flow Metab 1994, 14:12-19.
107. Dumuis A., Sebben M., Haynes L., Pin J.P., Bockaert J. NMDA receptors activate the arachidonic acid cascade system in striatal neurons. Nature 1988, 336:68-70.
108. Lazarewicz J.W., Wroblewski J.T., Costa E. N-methyl-D-aspartate-sensitive glutamate receptors induce calcium-mediated arachidonic acid release in primary cultures of cerebellar granule cells. J Neurochem 1990, 55:1875-1881.
109. Miller B., Sarantis M., Traynelis S.F., Attwell D. Potentiation of NMDA receptor currents by arachidonic acid. Nature 1992, 355:722-725.
110. Xiao Y.F., Kang J.X., Morgan J.P., Leaf A. Blocking effects of polyunsaturated fatty acids on Na+ channels of neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A 1995, 92:11000-11004.
111. Xiao Y.F., Ma L., Wang S.Y., Josephson M.E., Wang G.K., Morgan J.P., et al. Potent block of inactivation-deficient Na+ channels by n-3 polyunsaturated fatty acids. Am J Physiol Cell Physiol 2006, 290(2):C362-C370.
112. Vreugdenhil M., Bruehl C., Voskuyl R.A., Kang J.X., Leaf A., Wadman W.J. Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons. Proc Natl Acad Sci U S A 1996, 93(22):12559-12563.
113. Kang J.X., Leaf A. Effects of long-chain polyunsaturated fatty acids on the contraction of neonatal rat cardiac myocytes. Proc Natl Acad Sci U S A 1994, 91:9886-9890.
114. Xiao Y.F., Gomez A.M., Morgan J.P., Lederer W.J., Leaf A. Suppression of voltage-gated L-type Ca2+ currents by polyunsaturated fatty acids in adult and neonatal rat ventricular myocytes. Proc Natl Acad Sci U S A 1997, 94:4182-4187.
115. Xiao Y.F., Ke Q., Chen Y., Morgan J.P., Leaf A. Inhibitory effect of n-3 fish oil fatty acids on cardiac Na+/Ca2+ exchange currents in HEK293t cells. Biochem Biophys Res Commun 2004, 321:116-123.
116. Menard C., Patenaude C., Gagne A.M., Massicotte G. AMPA receptor-mediated cell death is reduced by docosahexaenoic acid but not by eicosapentaenoic acid in area CA1 of hippocampal slice cultures. J Neurosci Res 2009, 87:876-886.
117. Aid S., Vancassel S., Linard A., Lavialle M., Guesnet P. Dietary docosahexaenoic acid [22: 6(n-3)] as a phospholipid or a triglyceride enhances the potassium chloride-evoked release of acetylcholine in rat hippocampus. J Nutr 2005, 135:1008-1013.
118. Aid S., Vancassel S., Poumes-Ballihaut C., Chalon S., Guesnet P., Lavialle M. Effect of a diet-induced n-3 PUFA depletion on cholinergic parameters in the rat hippocampus. J Lipid Res 2003, 44(8):1545-1551.
119. Ikemoto A., Nitta A., Furukawa S., Ohishi M., Nakamura A., Fujii Y., et al. Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci Lett 2000, 285(2):99-102.
120. Dykens J.A. Isolated cerebral and cerebellar mitochondria produce free radicals when exposed to elevated implications for neurodegeneration. J Neurochem 1994, 63:584-591.
121. Won S.J., Kim D.Y., Gwag B.J. Cellular and molecular pathways of ischemic neuronal death. J Biochem Mol Biol 2002, 35:67-86.
122. Wang D., An S.C., Zhang X. Prevention of chronic stress-induced depression-like behavior by inducible nitric oxide inhibitor. Neurosci Lett 2008, 433:59-64.
123. Clarkson A.N., Sutherland B.A., Appleton I. The biology and pathology of hypoxia-ischemia: an update. Arch Immunol Ther Exp (Warsz) 2005, 53:213-225.
124. Chen L.Y., Lawson D.L., Mehta J.L. Reduction in human neutrophil superoxide anion generation by n-3 p.lyunsaturated fatty acids: role of cyclooxygenase products and endothelium-derived relaxing factor. Thromb Res 1994, 76:317-322.
125. Kolla N., Wei Z., Richardson J.S., Li X.M. Amitriptyline and fluoxetine protect PC12 cells from cell death induced by hydrogen peroxide. J Psychiatry Neurosci 2005, 30:196-201.
126. Cheon E.W., Park C.H., Kang S.S., Cho G.J., Yoo J.M., Song J.K., et al. Change in endothelial nitric oxide synthase in the rat retina following transient ischemia. Neuroreport 2003, 14(3):329-333.
127. Chan P.H. Reactive oxygen radicals in signaling and damage in the ischemic brain. J Cereb Blood Flow Metab 2001, 21:2-14.
128. Lara N., Archer S.L., Baker G.B., Le Melledo J.M. Paroxetine-induced increase in metabolic end products of nitric oxide. J Clin Psychopharmacol 2003, 23:408-412.
129. Okuda Y., Kawashima K., Sawada T., Tsurumaru K., Asano M., Suzuki S., et al. Eicosapentaenoic acid enhances nitric oxide production by cultured human endothelial cells. Biochem Biophys Res Commun 1997, 232(2):487-491.
130. Li Q., Zhang Q., Wang M., Zhao S., Ma J., Luo N., et al. Eicosapentaenoic acid modifies lipid composition in caveolae and induces translocation of endothelial nitric oxide synthase. Biochimie 2007, 89(1):169-177.
131. Iadecola C., Zhang F., Casey R., Clark H.B., Ross M.E. Inducible nitric oxide synthase gene expression in vascular cells after transient focal cerebral ischemia. Stroke 1996, 27:1373-1380.
132. Xu J., He L., Ahmed S.H., Chen S.W., Goldberg M.P., Beckman J.S., et al. Oxygen-glucose deprivation induces inducible nitric oxide synthase and nitrotyrosine expression in cerebral endothelial cells. Stroke 2000, 31(7):1744-1751.
133. Ohata T., Fukuda K., Takahashi M., Sugimura T., Wakabayashi K. Suppression of nitric oxide production in lipopolysaccharide-stimulated macrophage cells by omega 3 polyunsaturated fatty acids. Jpn J Cancer Res 1997, 88:234-237.
134. Marion-Letellier R., Butler M., Dechelotte P., Playford R.J., Ghosh S. Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells-potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation. Am J Clin Nutr 2008, 87:939-948.
135. Xia Y., Feng X., Chen Y., Su Y. Effects of EPA, DHA on the secretion of NO, expression of iNOS mRNA and DNA-binding activity of NFkappaB in human monocyte. Wei Sheng Yan Jiu 2007, 36:445-448.
136. Fisher M., Levine P.H., Weiner B.H., Johnson M.H., Doyle E.M., Ellis P.A., et al. Dietary n-3 fatty acid supplementation reduces superoxide production and chemiluminescence in a monocyte-enriched preparation of leukocytes. Am J Clin Nutr 1990, 51(5):804-808.
137. Fisher M., Upchurch K.S., Levine P.H., Johnson M.H., Vaudreuil C.H., Natale A., et al. Effects of dietary fish oil supplementation on polymorphonuclear leukocyte inflammatory potential. Inflammation 1986, 10(4):387-392.
138. Rizzo M.T., Regazzi E., Garau D., Akard L., Dugan M., Boswell H.S., et al. Induction of apoptosis by arachidonic acid in chronic myeloid leukemia cells. Cancer Res 1999, 59(19):5047-5053.
139. Surette M.E., Fonteh A.N., Bernatchez C., Chilton F.H. Perturbations in the control of cellular arachidonic acid levels block cell growth and induce apoptosis in HL-60 cells. Carcinogenesis 1999, 20:757-763.
140. de Kock M., Lottering M.L., Grobler C.J., Viljoen T.C., le Roux M., Seegers J.C. The induction of apoptosis in human cervical carcinoma (HeLa) cells by gamma-linolenic acid. Prostaglandins Leukot Essent Fatty Acids 1996, 55(6):403-411.
141. Finstad H.S., Drevon C.A., Kulseth M.A., Synstad A.V., Knudsen E., Kolset S.O. Cell proliferation, apoptosis and accumulation of lipid droplets in U937-1 cells incubated with eicosapentaenoic acid. Biochem J 1998, 336(Pt 2):451-459.
142. Calviello G., Palozza P., Piccioni E., Maggiano N., Frattucci A., Franceschelli P., et al. Dietary supplementation with eicosapentaenoic and docosahexaenoic acid inhibits growth of Morris hepatocarcinoma 3924A in rats: effects on proliferation and apoptosis. Int J Cancer 1998, 75(5):699-705.
143. Siddiqui R.A., et al. Cell-cycle arrest in Jurkat leukaemic cells: a possible role for docosahexaenoic acid. Biochem J 2003, 371:621-629.
144. Sweeney B., Puri P., Reen D.J. Induction and modulation of apoptosis in neonatal monocytes by polyunsaturated fatty acids. J Pediatr Surg 2007, 42:620-628.
145. Hirafuji M., Machida T., Tsunoda M., Miyamoto A., Minami M. Docosahexaenoic acid potentiates interleukin-1beta induction of nitric oxide synthase through mechanism involving p44/42 MAPK activation in rat vascular smooth muscle cells. Br J Pharmacol 2002, 136:613-619.
146. Field C.J., Schley P.D. Evidence for potential mechanisms for the effect of conjugated linoleic acid on tumor metabolism and immune function: lessons from n-3 fatty acids. Am J Clin Nutr 2004, 79:1190S-1198S.